Company Overview
ARCUTIS BIOTHERAPEUTICS, INC.
ARQTRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
376M
2025 FY
Net Income
-16M
2025 FY
Shares Outstanding
127M
2025 FY
EPS
-0.13USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1787306
Exchange
Nasdaq
Location
US